✉ Email this page to a colleague
« Back to Dashboard
Ecgonine is an investigational drug.
There have been 5 clinical trials for Ecgonine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Substance-Related Disorders, and Renal Insufficiency. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Baylor College of Medicine, and Johns Hopkins University.
Recent Clinical Trials for Ecgonine
|PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function||Cognitive Research Corporation||Phase 1|
|PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function||Pharmaceutical Project Solutions, Inc.||Phase 1|
|A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse||Indivior Inc.||Phase 2|